AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sonoma Pharmaceuticals, Inc. Director's Dealing 2017

Mar 13, 2017

35312_dirs_2017-03-13_ae8f68a7-3836-4404-9fb3-1729ecdd7907.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2017-03-09

Reporting Person: Miller Robert E (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-09	Common Stock, $0.0001 par value per share	P	250	$6.97	Acquired	7964	Indirect
2017-03-09	Common Stock, $0.0001 par value per share	P	250	$6.96	Acquired	8214	Indirect
2017-03-09	Common Stock, $0.0001 par value per share	P	250	$7.14	Acquired	8464	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value per share	15964	Direct

Footnotes

F1: These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees.